Searching News Database: LVAS
HSMN NewsFeed - 4 Feb 2020
Abbott's In-Development Fully Implantable Heart Pump System Earns FDA's Breakthrough Device Designation
Abbott's In-Development Fully Implantable Heart Pump System Earns FDA's Breakthrough Device Designation
HSMN NewsFeed - 12 Oct 2015
St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System
St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System
HSMN NewsFeed - 22 Sep 2014
Thoratec Appoints D. Keith Grossman President And Chief Executive Officer
Thoratec Appoints D. Keith Grossman President And Chief Executive Officer
HSMN NewsFeed - 7 Jan 2013
Thoratec Announces FDA Approval To Commence REVIVE-IT Study Utilizing HeartMate II
Thoratec Announces FDA Approval To Commence REVIVE-IT Study Utilizing HeartMate II
HSMN NewsFeed - 19 Jul 2011
German Patient Surpasses 5 Years of Support on DuraHeart Left Ventricular Assist Device
German Patient Surpasses 5 Years of Support on DuraHeart Left Ventricular Assist Device
HSMN NewsFeed - 20 Jan 2010
Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
HSMN NewsFeed - 31 Jul 2009
Thoratec Corporation and HeartWare International, Inc. Announce Termination of Proposed Transaction
Thoratec Corporation and HeartWare International, Inc. Announce Termination of Proposed Transaction
HSMN NewsFeed - 19 Jun 2009
Covidien Features New Devices for Minimally Invasive Surgery and Soft Tissue Repair at ASMBS 2009
Covidien Features New Devices for Minimally Invasive Surgery and Soft Tissue Repair at ASMBS 2009
HSMN NewsFeed - 20 Apr 2009
Thoratec Announces Filing of PMA Seeking Destination Therapy Approval for HeartMate II(R)
Thoratec Announces Filing of PMA Seeking Destination Therapy Approval for HeartMate II(R)
HSMN NewsFeed - 12 Mar 2009
I-Flow Corporation Receives FDA Clearance for Stabilized Antimicrobial Wound Gel
I-Flow Corporation Receives FDA Clearance for Stabilized Antimicrobial Wound Gel
HSMN NewsFeed - 13 Feb 2009
Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million
Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million
HSMN NewsFeed - 31 Oct 2008
First Implant of DuraHeart(TM) Left Ventricular Assist System (LVAS) in Japanese Clinical Trial
First Implant of DuraHeart(TM) Left Ventricular Assist System (LVAS) in Japanese Clinical Trial
HSMN NewsFeed - 21 Oct 2008
Fifth DuraHeart(TM) U.S. Implant Marks Important Milestone in U.S. Pivotal Trial
Fifth DuraHeart(TM) U.S. Implant Marks Important Milestone in U.S. Pivotal Trial
HSMN NewsFeed - 24 Sep 2008
I-Flow Corporation Receives 510(k) Clearance From FDA for Oxygenated Topical Dressing
I-Flow Corporation Receives 510(k) Clearance From FDA for Oxygenated Topical Dressing
HSMN NewsFeed - 6 Aug 2008
First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial
First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial
HSMN NewsFeed - 21 Apr 2008
Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
HSMN NewsFeed - 17 Sep 2007
Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results
Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results
HSMN NewsFeed - 15 Aug 2007
Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
HSMN NewsFeed - 27 Feb 2007
Terumo Heart Inc. Receives CE Mark for Left Ventricular Assist System in Europe
Terumo Heart Inc. Receives CE Mark for Left Ventricular Assist System in Europe
HSMN NewsFeed - 21 Dec 2006
Thoratec Completes Filing of PMA Seeking Bridge-to-Transplantation Approval for HeartMate(R) II
Thoratec Completes Filing of PMA Seeking Bridge-to-Transplantation Approval for HeartMate(R) II
HSMN NewsFeed - 14 Nov 2006
WorldHeart Announces $14.1 Million Private Placement and Plan to Restructure Its Business
WorldHeart Announces $14.1 Million Private Placement and Plan to Restructure Its Business
HSMN NewsFeed - 24 Aug 2006
Thoratec and Levitronix Announce U.S. Co-Distribution Agreement for Levitronix(R) CentriMag(R) System
Thoratec and Levitronix Announce U.S. Co-Distribution Agreement for Levitronix(R) CentriMag(R) System
HSMN NewsFeed - 27 Jul 2006
WorldHeart Announces Five Years of Novacor LVAS Support in a US Recipient
WorldHeart Announces Five Years of Novacor LVAS Support in a US Recipient
HSMN NewsFeed - 15 May 2006
WorldHeart's Next-Generation Rotary VAD Successfully Implanted in Second Patient
WorldHeart's Next-Generation Rotary VAD Successfully Implanted in Second Patient
HSMN NewsFeed - 24 Apr 2006
FDA Approves Almost 50% Reduction in Size of WorldHeart's RELIANT Destination Therapy Trial
FDA Approves Almost 50% Reduction in Size of WorldHeart's RELIANT Destination Therapy Trial
HSMN NewsFeed - 18 Apr 2006
First Patient Recovering Well With WorldHeart's Next-Generation Rotary VAD
First Patient Recovering Well With WorldHeart's Next-Generation Rotary VAD
HSMN NewsFeed - 10 Apr 2006
Study Reports WorldHeart Novacor LVAS Patients Enjoy Higher Quality of Life
Study Reports WorldHeart Novacor LVAS Patients Enjoy Higher Quality of Life
HSMN NewsFeed - 1 Mar 2006
Thoratec Says New HFSA Guidelines Reflect Growing Acceptance of VADs for Treating Heart Failure Patients
Thoratec Says New HFSA Guidelines Reflect Growing Acceptance of VADs for Treating Heart Failure Patients
HSMN NewsFeed - 17 Jan 2006
Thoratec Corporation Names Gary Burbach President and Chief Executive Officer
Thoratec Corporation Names Gary Burbach President and Chief Executive Officer
Additional items found! 104
Members Archive contains
104 additional stories matching:
LVAS
(Password required)
LVAS
(Password required)
